Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 16.80
0.00 (0.00%)
At close: Apr 7, 2026
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €126.41 million as of April 7, 2026. Its market cap has increased by 483.33% in one year.
Market Cap
126.41M
Enterprise Value
124.54M
Revenue
8.09M
Ranking
n/a
PE Ratio
64.75
Stock Price
€16.80
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 126.41M, an increase of 722.49%. That is a compound annual growth rate of 68.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 127.91M | 98.83% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.72B |
| Laboratorios Farmaceuticos Rovi | 4.23B |
| Almirall | 2.65B |
| Pharma Mar | 1.58B |
| Clínica Baviera | 767.29M |
| Atrys Health | 217.76M |
| Prim, S.A. | 216.95M |
| Oryzon Genomics | 216.26M |